{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:28:09Z","timestamp":1648600089903},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T00:00:00Z","timestamp":1366243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11906-013-0352-5","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T06:55:32Z","timestamp":1366181732000},"page":"137-142","source":"Crossref","is-referenced-by-count":2,"title":["Role of Ambulatory Blood Pressure Monitoring in Hypertension and Diabetes"],"prefix":"10.1007","volume":"15","author":[{"given":"Colleen","family":"Flynn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,18]]},"reference":[{"key":"352_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217\u201323.","journal-title":"Lancet"},{"key":"352_CR2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","volume":"287","author":"RS Vasan","year":"2002","unstructured":"Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA: J Am Med Assoc. 2002;287:1003\u201310.","journal-title":"JAMA: J Am Med Assoc"},{"key":"352_CR3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206\u201352.","journal-title":"Hypertension"},{"key":"352_CR4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","volume":"380","author":"BK Mahmoodi","year":"2012","unstructured":"\u2022 Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012;380:1649\u201361. Meta-analysis of trials involving over one million patients documenting presence of kidney disease to be independent of hypertension as a risk factor for all cause mortality.","journal-title":"Lancet"},{"key":"352_CR5","doi-asserted-by":"crossref","unstructured":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis: J Natl Kidney Foundation. 2007; 49:S12\u2013154.","DOI":"10.1053\/j.ajkd.2006.12.005"},{"issue":"Suppl 5A","key":"352_CR6","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1016\/j.amjmed.2003.10.018","volume":"116","author":"GL Bakris","year":"2004","unstructured":"Bakris GL. The importance of blood pressure control in the patient with diabetes. Am J Med. 2004;116(Suppl 5A):30S\u20138S.","journal-title":"Am J Med"},{"key":"352_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1751-7176.2008.07309.x","volume":"10","author":"PA Sarafidis","year":"2008","unstructured":"Sarafidis PA, Bakris GL. State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens. 2008;10:130\u20139.","journal-title":"J Clin Hypertens"},{"issue":"Suppl 1","key":"352_CR8","first-page":"S11","volume":"35","author":"American Diabetes A","year":"2012","unstructured":"American Diabetes A. Standards of medical care in diabetes\u20132012. Diabetes Care. 2012;35 Suppl 1:S11\u201363.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"352_CR9","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes A","year":"2013","unstructured":"\u2022\u2022 American Diabetes A. Standards of medical care in diabetes\u20132013. Diabetes Care. 2013;36 Suppl 1:S11\u201366. Presence new guidance for blood pressure goal in diabetes as <140\/80 mmHg and supports better evaluation of blood pressure in patients with diabetes.","journal-title":"Diabetes Care"},{"key":"352_CR10","unstructured":"\u2022\u2022 Wheeler DC, Becker GJ. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney international 2013-online. Presents the evidence that supports a blood pressure level <140\/90 mmHg in kidney disease to slow progression and not <130\/80 mmHg. It is a summary of the broadeer guidelines for blood pressure published in the Kidney International Supplement."},{"key":"352_CR11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290\u2013300.","journal-title":"Am J Med"},{"key":"352_CR12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/157016112799304996","volume":"10","author":"RG Kalaitzidis","year":"2012","unstructured":"Kalaitzidis RG, Bakris GL. Pros and cons of aggressive blood pressure lowering in patients with type 2 diabetes. Curr Vasc Pharmacol. 2012;10:156\u201361.","journal-title":"Curr Vasc Pharmacol"},{"key":"352_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","volume":"478","author":"GB Ehret","year":"2011","unstructured":"\u2022\u2022 International Consortium for Blood Pressure Genome-Wide Association S, Ehret GB, Munroe PB, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103\u20139. Presents evidence for systems involved in the genesis of hypertension and of note, the natriuretic peptides are prominently featured but not the renin angiotensin system.","journal-title":"Nature"},{"key":"352_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ajcn\/88.2.255","volume":"88","author":"PR Conlin","year":"2008","unstructured":"Conlin PR. Genes and environment in blood pressure control\u2013salt intake again shows its importance. Am J Clin Nutr. 2008;88:255\u20136.","journal-title":"Am J Clin Nutr"},{"key":"352_CR15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1559-4564.2006.05795.x","volume":"1","author":"PA Sarafidis","year":"2006","unstructured":"Sarafidis PA, Bakris GL. Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach. J Cardiometabolic Syndrome. 2006;1:334\u201342. quiz 343.","journal-title":"J Cardiometabolic Syndrome"},{"key":"352_CR16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s12098-012-0777-x","volume":"79","author":"LJ Becton","year":"2012","unstructured":"Becton LJ, Shatat IF, Flynn JT. Hypertension and obesity: epidemiology, mechanisms and clinical approach. Indian J Pediatr. 2012;79:1056\u201361.","journal-title":"Indian J Pediatr"},{"key":"352_CR17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.HYP.4.5.686","volume":"4","author":"JR Sowers","year":"1982","unstructured":"Sowers JR, Nyby M, Stern N, et al. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension. 1982;4:686\u201391.","journal-title":"Hypertension"},{"key":"352_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3945\/ajcn.2009.29028","volume":"92","author":"MS Yatabe","year":"2010","unstructured":"Yatabe MS, Yatabe J, Yoneda M, et al. Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr. 2010;92:77\u201382.","journal-title":"Am J Clin Nutr"},{"key":"352_CR19","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.yexcr.2011.07.016","volume":"317","author":"G Liu","year":"2011","unstructured":"Liu G, Hitomi H, Hosomi N, et al. Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor. Exp Cell Res. 2011;317:2420\u20138.","journal-title":"Exp Cell Res"},{"key":"352_CR20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db10-1011","volume":"60","author":"AT Kraja","year":"2011","unstructured":"\u2022 Kraja AT, Vaidya D, Pankow JS, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011;60:1329\u201339. A GWAS evalauting the an approach to metabolic syndrome.","journal-title":"Diabetes"},{"key":"352_CR21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ajh.2011.188","volume":"25","author":"SK Patel","year":"2012","unstructured":"Patel SK, Wai B, Ord M, et al. Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes. Am J Hypertens. 2012;25:216\u201322.","journal-title":"Am J Hypertens"},{"key":"352_CR22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1097\/00004872-199917110-00010","volume":"17","author":"K Bengtsson","year":"1999","unstructured":"Bengtsson K, Orho-Melander M, Lindblad U, et al. Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and diabetes project. J Hypertens. 1999;17:1569\u201375.","journal-title":"J Hypertens"},{"key":"352_CR23","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/ndt\/15.7.1000","volume":"15","author":"FJ Ittersum van","year":"2000","unstructured":"van Ittersum FJ, de Man AM, Thijssen S, et al. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant: Off Publication of the European Dialysis and Transplant Association - European Renal Association. 2000;15:1000\u20137.","journal-title":"Nephrol Dial Transplant: Off Publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"352_CR24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1590\/S0066-782X2011005000107","volume":"97","author":"VP Wobeto","year":"2011","unstructured":"Wobeto VP, Pinho Pda C, Souza JR, et al. Haptoglobin genotypes and refractory hypertension in type 2 diabetes mellitus patients. Arq Bras Cardiol. 2011;97:338\u201345.","journal-title":"Arq Bras Cardiol"},{"key":"352_CR25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/ki.2010.488","volume":"79","author":"Y Wu","year":"2011","unstructured":"Wu Y, Xu J, Velazquez H, et al. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2011;79:853\u201360.","journal-title":"Kidney Int"},{"key":"352_CR26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI24066","volume":"115","author":"J Xu","year":"2005","unstructured":"Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Investig. 2005;115:1275\u201380.","journal-title":"J Clin Investig"},{"key":"352_CR27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12017-011-8158-6","volume":"13","author":"M Buraczynska","year":"2011","unstructured":"Buraczynska M, Zukowski P, Buraczynska K, et al. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med. 2011;13:321\u20137.","journal-title":"Neuromolecular Med"},{"key":"352_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199301073280102","volume":"328","author":"LC Groop","year":"1993","unstructured":"Groop LC, Kankuri M, Schalin-Jantti C, et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med. 1993;328:10\u20134.","journal-title":"N Engl J Med"},{"key":"352_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/HYPERTENSIONAHA.107.189011","volume":"52","author":"TG Pickering","year":"2008","unstructured":"Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1\u20139.","journal-title":"Hypertension"},{"key":"352_CR30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/ajh.2011.72","volume":"24","author":"EA Furusawa","year":"2011","unstructured":"\u2022 Furusawa EA, Filho UD, Junior DM, Koch VH. Home and ambulatory blood pressure to identify white coat and masked hypertension in the pediatric patient. Am J Hypertension. 2011;24:893\u20137. Arguments for home blood pressures as an alternative to ambulatory blood pressure to identify white coat hypertension.","journal-title":"Am J Hypertension"},{"key":"352_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/HYPERTENSIONAHA.111.00100","volume":"61","author":"TJ Niiranen","year":"2013","unstructured":"\u2022\u2022 Niiranen TJ, Asayama K, Thijs L, et al. Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension. 2013;61:27\u201334. An outcomes based analysis of internatioanl data evaluating home blood pressure as a way to identify patterns of blood pressure and identify risk.","journal-title":"Hypertension"},{"key":"352_CR32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1751-7176.2012.00648.x","volume":"14","author":"K Eguchi","year":"2012","unstructured":"Eguchi K, Hoshide S, Ishikawa S, et al. Aggressive blood pressure-lowering therapy guided by home blood pressure monitoring improves target organ damage in hypertensive patients with type 2 diabetes\/prediabetes. J Clin Hypertens. 2012;14:422\u20138.","journal-title":"J Clin Hypertens"},{"key":"352_CR33","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1136\/bmj.e181","volume":"344","author":"RJ McManus","year":"2012","unstructured":"McManus RJ, Caulfield M, Williams B, et al. NICE hypertension guideline 2011: evidence based evolution. BMJ. 2012;344:e181.","journal-title":"BMJ"},{"key":"352_CR34","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895\u2013905.","journal-title":"Lancet"},{"key":"352_CR35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrcardio.2011.75","volume":"8","author":"D Zhao","year":"2011","unstructured":"Zhao D, Qi Y, Zheng Z, et al. Dietary factors associated with hypertension. Nat Rev Cardiol. 2011;8:456\u201365.","journal-title":"Nat Rev Cardiol"},{"key":"352_CR36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1469-8986.2007.00629.x","volume":"45","author":"JD McNeely","year":"2008","unstructured":"McNeely JD, Windham BG, Anderson DE. Dietary sodium effects on heart rate variability in salt sensitivity of blood pressure. Psychophysiology. 2008;45:405\u201311.","journal-title":"Psychophysiology"},{"key":"352_CR37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000339165","volume":"35","author":"L Shao","year":"2012","unstructured":"Shao L, Lang Y, Wang Y, et al. High-frequency variant p.T60M in NaCl cotransporter and blood pressure variability in Han Chinese. Am J Nephrol. 2012;35:515\u20139.","journal-title":"Am J Nephrol"},{"key":"352_CR38","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjhyper.2004.08.031","volume":"18","author":"N Boudville","year":"2005","unstructured":"Boudville N, Ward S, Benaroia M, House AA. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens. 2005;18:1300\u20135.","journal-title":"Am J Hypertens"},{"key":"352_CR39","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","volume":"60","author":"National Kidney F","year":"2012","unstructured":"\u2022\u2022 National Kidney F. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis: the official journal of the National Kidney Foundation. 2012;60:850\u201386. Latest guidance on hypertension and kidney disease in diabetes.","journal-title":"Am J Kidney Dis: the official journal of the National Kidney Foundation"},{"key":"352_CR40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.112.200477","volume":"61","author":"M Rahman","year":"2013","unstructured":"Rahman M, Greene T, Phillips RA, et al. A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension. 2013;61:82\u20138.","journal-title":"Hypertension"},{"key":"352_CR41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJMc1001410","volume":"363","author":"KA Jamerson","year":"2010","unstructured":"Jamerson KA, Bakris GL, Weber MA. 24-hour ambulatory blood pressure in the ACCOMPLISH trial. N Engl J Med. 2010;363:98.","journal-title":"N Engl J Med"},{"key":"352_CR42","doi-asserted-by":"crossref","first-page":"1229 e1221","DOI":"10.1016\/j.amjmed.2012.05.023","volume":"125","author":"GL Bakris","year":"2012","unstructured":"Bakris GL, Sica D, White WB, et al. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. Am J Med. 2012;125:1229 e1221\u201310.","journal-title":"Am J Med"},{"key":"352_CR43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.HYP.0000216634.73504.7d","volume":"47","author":"A Moran","year":"2006","unstructured":"Moran A, Palmas W, Pickering TG, et al. Office and ambulatory blood pressure are independently associated with albuminuria in older subjects with type 2 diabetes. Hypertension. 2006;47:955\u201361.","journal-title":"Hypertension"},{"key":"352_CR44","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/HYPERTENSIONAHA.112.199562","volume":"60","author":"G Mancia","year":"2012","unstructured":"Mancia G, Parati G, Bilo G, et al. Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension. 2012;60:1400\u20136.","journal-title":"Hypertension"},{"key":"352_CR45","first-page":"793","volume":"17","author":"KA Jamerson","year":"2004","unstructured":"Jamerson KA, Bakris GL, Wun CC, et al. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension. Am J Hypertens. 2004;17:793\u2013801.","journal-title":"Am J Hypertens"},{"key":"352_CR46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","volume":"56","author":"MA Weber","year":"2010","unstructured":"Weber MA, Bakris GL, Jamerson K, et al. Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol. 2010;56:77\u201385.","journal-title":"J Am Coll Cardiol"},{"key":"352_CR47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","volume":"120","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120:713\u20139.","journal-title":"Am J Med"},{"key":"352_CR48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2146\/ajhp060434","volume":"64","author":"PP Gerbino","year":"2007","unstructured":"Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health-Syst Pharma: AJHP: official journal of the American Society of Health-System Pharmacists. 2007;64:1279\u201383.","journal-title":"Am J Health-Syst Pharma: AJHP: official journal of the American Society of Health-System Pharmacists"},{"key":"352_CR49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/HYPERTENSIONAHA.110.156976","volume":"56","author":"GL Bakris","year":"2010","unstructured":"Bakris GL, Lindholm LH, Black HR, et al. Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. Hypertension. 2010;56:824\u201330.","journal-title":"Hypertension"},{"key":"352_CR50","doi-asserted-by":"crossref","unstructured":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317:703\u2013713.","DOI":"10.1136\/bmj.317.7160.703"},{"key":"352_CR51","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"AS Group","year":"2010","unstructured":"Group AS, Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575\u201385.","journal-title":"N Engl J Med"},{"key":"352_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","volume":"304","author":"RM Cooper-DeHoff","year":"2010","unstructured":"Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA: J Am Med Assoc. 2010;304:61\u20138.","journal-title":"JAMA: J Am Med Assoc"},{"key":"352_CR53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA: J Am Med Assoc. 2010;303:235\u201341.","journal-title":"JAMA: J Am Med Assoc"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-013-0352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-013-0352-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-013-0352-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T14:47:20Z","timestamp":1562942840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-013-0352-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,18]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1007\/s11906-013-0352-5","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,18]]}}}